Chronic lymphocytic leukemia-associated pure red cell aplasia

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 2, 2009, Pages 279-286

  D'Arena, Giovanni ^a   Cascavilla, N ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Alemtuzumab; Chronic lymphocytic leukemia; Pure red cell aplasia; Rituximab; Therapy

Indexed keywords

ALEMTUZUMAB; BILIRUBIN; CD16 ANTIGEN; CYCLOSPORIN A; HAPTOGLOBIN; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

ADVANCED CANCER; ANTIBODY PRODUCING CELL; APOPTOSIS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; BILIRUBIN BLOOD LEVEL; BLACKFAN DIAMOND ANEMIA; BONE MARROW CANCER; BONE MARROW CELL; CAUSAL ATTRIBUTION; CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; COOMBS TEST; CYTOLYSIS; DISEASE ASSOCIATION; DRUG COST; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ERYTHROBLASTOPENIA; ERYTHROPOIESIS; HEMOLYSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; PARVOVIRUS INFECTION; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURE RED CELL ANEMIA; RELAPSE; REMISSION; RETICULOCYTOSIS; REVIEW; RHEUMATOID ARTHRITIS; STEROID THERAPY; SUPPRESSOR CELL; T LYMPHOCYTE; TARGET CELL DESTRUCTION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 67650468319     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200204     Document Type: Review

References (50)

1. Dessypris EN. Pure red cell aplasia. In: Hematology Basic Principles and Practice. Hoffman R, Benz Jr EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P, eds. Philadelphia: Elsevier Churchill Livingstone; 2005; pp. 429-439.
2. Diamond LK. Congenital hypoplastic anemia: Diamond-Blackfan syndrome. Historical and clinical aspects. Blood Cells 1978; 4:209-213
3. Chikkappa G, Zarrabi MH, Tsan MF. Pure red cell aplasia in patients with chronic lymphocytic leukemia. Medicine 1986; 65:339-351 (Pubitemid 17180483)
4. Diehl LF, Ketchum LH. Autoimmune diseases and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998; 25:80-97. (Pubitemid 28090915)
5. Hamblin TJ. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Cheson BD, ed. Chronic lymphoid leukemias. New York: Marcel Dekker; 2000; pp. 435-458
6. D'Arena G, Cascavilla N. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leuk Lymphoma 2007; 48:1072-1080 (Pubitemid 47009197)
7. Young NS, Abkowitz JL, Luzzatto L. New insights into the pathophysiology of acquired cytopenias. Am Soc Hematol Educ Program 2000:18-38.
8. Krantz SB, Kao V. Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci USA 1967; 58:493-500.
9. Krantz SB, Kao V. Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy. Blood 1969; 34:1-13.
10. Krantz SB, Moore WH, Zaentz SD. Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. J Clin Invest 1973; 52: 324-336
11. Zaentz SD, Krantz SB. Studies on pure red cell aplasia. VI. Development of two-stage erythroblast cytotoxicity method and role of complement. J Lab Clin Med 1973; 82:31-43.
12. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996; 87:4831-4838 (Pubitemid 26162386)
13. Keel S, Abkowitz JL. Pure red cell aplasia and Diamond-Blackfan anemia. In: Young NS, Gerson SL, High KA Eds. Clinical Hematology. Mosby Elsevier, Philadelphia, USA, 2006; pp. 169-180.
14. Hoffman R, Kopel S, Hsu SD, Dainiak N, Zanjani ED. T-cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood 1978; 52: 255-260
15. Mangan KF, Chikkappa G, Scharfman WB, Desforges JF. Evidence for reduced erythroid burst (BFU-E) promoting function of T lymphocytes in the pure red cell aplasia of chronic lymphocytes in the pure red cell aplasia of chronic lymphocytic leukemia. Exp Hematol 1981; 9:489-498
16. Mangan KF, Chikkappa G, Bieler LZ, Scharfhan WB, Parkinson DR. Regulation of human blood erythroid burst-forming unit (BFU-E) proliferation by T-lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. Blood 1982; 59:990-996
17. Mangan KF, Chikkappa G, Farley PC. T gamma (Tγ) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. J Clin Invest 1982; 70:1148-1156 (Pubitemid 13167995)
18. Mangan KF, D'Alessandro L. Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell mediated suppression of erythropoiesis in early-stage and late-stage disease. Blood 1985; 66: 533-541 (Pubitemid 15230755)
19. Abkowitz JL, Kadin ME, Powell JS, Adamson JW. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol 1986; 63:59-67. (Pubitemid 16113730)
20. Mangan KF, Volkin R, Winkelstein A. Autoreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymoma and panh ypogammaglobulinemia. Am J Hematol 1986; 23: 167-173 (Pubitemid 16019887)
21. Hakard LP, Brandt J, Lu L, Jansen J, Hoffman R. Chronic T cell lymphoproliferative disorder and pure red cell aplasia. Am J Med 1987; 83:1069-1074
22. Nagasawa T, Abe T, Nakagawa T. Pure red cell aplasia and hypogammaglobulinemia associated with Tr-cell chronic lymphocytic leukemia. Blood 1981; 57:1025-1031 (Pubitemid 11050804)
23. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996; 87:3000-3006 (Pubitemid 26102252)
24. Handgretinger R, Geiselhart A, Moris A, Grau R, Teuffel O, Bethge W, Kanz L, Fisch P. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 1999; 340:278-284 (Pubitemid 29063270)
25. Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Progr 2001; 259-281
26. Vashi P, Patel B, Musson P, Fahrner J, Rosenbaum R. Corticosteroid- responsive pure red cell aplasia in chronic lymphocytic leukemia. Am J Hematol 1987; 26:279-284 (Pubitemid 18020044)
27. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008; 142:505-514 (Pubitemid 352020200)
28. Chikkappa G, Pasquale D, Phillips PG, Mangan KF, Tsan MF. Cyclosporin-A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia. Am J Hematol 1987; 26:179-189 (Pubitemid 17159693)
29. Cesana C, Carlo-Stella C, Mangoni L, Almici C, Giachetti R, Zappa M, Rizzoli V. Response to cyclosporin A and recombinant human erythropoietin in a case of B cell chronic lymphocytic leukemia and pure red cell aplasia. Leukemia 1996; 10:1400-1401 (Pubitemid 26261443)
30. Tura S, Finelli C, Bandini G, Cavo M, Gobbi M. Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia. Nouv Rev Fr Hematol 1988; 30:479-481 (Pubitemid 19011885)
31. Finelli C, bandini G, Ricci P, Giudice V, Vianelli N, Rabbi C, Raspadori D, Tura S. Cyclosporin A in idiopathic and CLL-associated pure red cell aplasia. Haematologica 1987; 72:537-540
32. Christen R, Morant R, Fehr J. Cyclosporin A therapy of pure red cell aplasia in a patient with B-cell chronic lymphocytic leukaemia. Eur J Haematol 1989; 42:303-307 (Pubitemid 19086217)
33. Yamada O, Yun-Hua W, Motoji T, Mizoguchi H. Clonal T-cell proliferation causing pure red cell aplasia in chronic B-cell lymphocytic leukemia: successful treatment with cyclosporine following in vitro abrogation of erythroid colony-suppressing activity. Br J Haematol 1998; 101:335-337 (Pubitemid 28261122)
34. Gotic M, Basara N, Rolovic Z, Boskovic D, Antunovic P, Marisavljevic D, Brkic S. Successful treatment of refractory pure red cell aplasia secondary to chronic lymphocytic leukemia with cyclosporine A: correlation between clinical and in vitro effects. Nouv Rev Fr Hematologie 1994; 36: 307-309 (Pubitemid 24285651)
35. Sivakumaran M, Bhavnani M. Cyclosporin therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia (letter; comment). Am J Hematol 1994; 45:192. (Pubitemid 24092593)
36. Chikkappa G, Pasquale D, Zarrabi MH, Weiler RJ, Divakara M, Tsan MF. Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia. Am J hematol 1992; 41:5-12.
37. Cortes J, O'Brien S, Loscertales J, Kantarjian H, Giles F, Thomas D, Koller C, Keating M. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. Cancer 2001; 92: 2016-2022 (Pubitemid 32973308)
38. Singal R, Winfield DA, Greaves M. Bone marrow aplasia in B cell chronic lymphocytic leukaemia: successful treatment with antithymocyte globulin. J Clin Pathol 1991; 44:954-956
39. Radosevich CA, Gordon LI, Weil SC, Marder RJ, Rosen ST. Complete resolution of pure red cell aplasia in a patient with chronic lymphocytic leukemia following antithymocyte globulin therapy. JAMA 1988; 259:723-725 (Pubitemid 18039570)
40. Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood 2002; 99:1092-1094 (Pubitemid 34525578)
41. Battle M, Ribera J-M, Oriol A, Pensa E, Milla F, Feliu E. Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia. Br J Haematol 2002; 118: 1190-1200 (Pubitemid 35025992)
42. Ru X, Liebman HA. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J haematol 2003; 123:278-281 (Pubitemid 37305062)
43. Pantelidou D, Tsatalas C, margaritis D, Kaloutsi V, Spanoudakis E, Bopurikas G. Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukaemia-associated pure red cell aplasia. Hematol J 2004; 5:546-547
44. Narra K, Borghaei H, Al-Saleem T, Hoglund M, Smith MR. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leuk Res 2006; 30:109-114 (Pubitemid 41654714)
45. D'Arena G, Vigliotti ML, Dell'Olio M, et al. Rituximab to treat chronic lymphoproliferative disorders-associated pure red cell aplasia. Eur J Haematol 2009; 82:235-239
46. Scrivener S, Goddard RV, Kaminski ER, Prentice AG. Abnormal T-cell function in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2003; 44:383-389 (Pubitemid 36118829)
47. Hamblin TJ, Orchard JA, Myint H, Oscier DG. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia (letter). J Clin Oncol 1998; 16:3209-3210 (Pubitemid 28417451)
48. Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska M, Cooper N, Amadori S. Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 2007; 110:2924-2930 (Pubitemid 350006946)
49. Rodon P, Breton P, Courouble G. Treatment of pure red cell aplasia and autoimmune haemolytic anemia in chronic lymphocytic leukaemia with Campath-1H. Eur J Haematol 2003; 70:319-321 (Pubitemid 36560531)
50. Hale G, Xia MQ, Tighe HP, Dyer MJS, Waldmann H. The Campath-1H antigen (CD52). Tissue Antigen 1990; 35:118-127